Anika
-
Top Stories
Anika Appoints New Chief Medical Officer and Chief Operations Officer
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Extremities
Anika Therapeutics Wins CE Mark Approval for Cingal® for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its…
Read More » -
Biologics
Anika Therapeutics Announces Regulatory Submissions with U.S. FDA and European Regulatory Authorities for Cingal®
BEDFORD, Mass–(BUSINESS WIRE)–Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid…
Read More » -
Biologics
Anika Therapeutics Reports Third-Quarter 2014 Financial Results Along With New J-Code
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic…
Read More » -
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
BEDFORD, Mass., Dec 31, 2009 (BUSINESS WIRE) — Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has acquired Fidia…
Read More »